Bison Wealth’s Immunomedics Inc IMMU Stock Holding History

Bison Wealth’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-10,000	Closed	-$65K	–	197
2017 Q1	$65K	Hold	10,000	–	–	0.06%	173
2016 Q4	$37K	Buy	+10,000	New	+$29.6K	0.03%	184

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Bison Wealth's IMMU Position: Q2 2017 in Review

Bison Wealth sold out of Immunomedics Inc (IMMU) in Q2 2017, closing a stake of 10,000 shares — an estimated $65K sold.

Bison Wealth first reported a position in IMMU in Q4 2016 and held it in 2 quarters. The position peaked at $65K in Q1 2017. 130 funds tracked by Wall St. Rank hold IMMU as of Q2 2017.

Bison Wealth reported no remaining Immunomedics Inc position as of Q2 2017 after selling out during the quarter.
Bison Wealth sold 10,000 Immunomedics Inc shares in Q2 2017, an estimated $65K.
Bison Wealth first reported a position in Immunomedics Inc in Q4 2016 and held it in 2 quarters.
Bison Wealth's Immunomedics Inc position peaked at $65K in Q1 2017.
130 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2017.

Based on Bison Wealth's 13F filing for Q2 2017, filed 1 Aug 2017.